Concepedia

Ami Patel

AP

Statistics

Publications

49

Citations

3.7K

H-Index

31

Active since

2000

Affiliations

Inovio Pharmaceuticals (United States)(Current)

The Wistar Institute

Public Health Agency of Canada

University of Pennsylvania

University of Manitoba

Ami Patel is an author at Inovio Pharmaceuticals (United States) specializing in vaccinology, immunology, and infectious diseases.

ORCID

Publications per year

2000–2025

49

Publications

49

Immunogenicity of a DNA vaccine candidate for COVID-19

Trevor R.F. Smith, Ami Patel, Stephanie Ramos et al. · Nature Communications · 2020 · 640 citations · Full text

, , +17

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

Kayvon Modjarrad, Christine C. Roberts, Kristin T Mills et al. · The Lancet Infectious Diseases · 2019 · 322 citations · Full text

, , +13

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 282 citations · Full text

, , +17

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

Kar Muthumani, Darryl Falzarano, Emma L. Reuschel et al. · Science Translational Medicine · 2015 · 255 citations · Full text

, , +17

Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice

Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. · PLoS ONE · 2008 · 176 citations · Full text

, , +17

1–5 of 49